Usana Health Sciences
USNA
155 hedge funds and large institutions have $593M invested in Usana Health Sciences in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 16 closing their positions.
69% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 16
4% more funds holding
Funds holding: 149 → 155 (+6)
1.19% more ownership
Funds ownership: 40.78% → 41.98% (+1.2%)
9% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 46
3% less capital invested
Capital invested by funds: $609M → $593M (-$15.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$39M |
| 2 |
Renaissance Technologies
New York
|
+$7.69M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.09M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$5.06M |
| 5 |
AP
AHL Partners
London,
United Kingdom
|
+$5.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$6.52M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$6.32M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.41M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.12M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$2.72M |
USNA Hedge Fund Activity: Q1 2017 in Review
155 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2017, worth a combined $593M — down 2.6% from $609M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new USNA positions and 16 closed out — a net gain of 11 holders — while 50 added to existing stakes and 46 trimmed.
The largest buyer was BlackRock, adding an estimated $39M. The largest seller was Bank of New York Mellon, cutting an estimated $6.52M.
- 155 institutional investors held Usana Health Sciences (USNA) as of Q1 2017, up from 149 in Q4 2016.
- Funds reported $593M of Usana Health Sciences stock for Q1 2017, down 2.6% quarter-over-quarter.
- 27 funds opened new Usana Health Sciences positions in Q1 2017 and 16 closed out, a net change of +11 holders.
- The largest Usana Health Sciences buyer in Q1 2017 was BlackRock, an estimated $39M added.
- The largest Usana Health Sciences seller in Q1 2017 was Bank of New York Mellon, an estimated $6.52M sold.
Based on aggregated 13F filings for Q1 2017.